Buys
Open market- Shares
- Avg price
- Total value
Fairmount Funds Management LLC - Director, 10%+ Owner at Oruka Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director, 10%+ Owner
- Issuer ticker
- ORKA on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Fairmount Funds Management LLC in Oruka Therapeutics, Inc.
Sells
Open market- Shares
- -3,553,410
- Avg price
- $84.43
- Total value
- -$300,014,406
Net
Past year- Shares
- -3,553,410
- Share %
- -100%
- Total value
- -$300,014,406
Reported holdings for Fairmount Funds Management LLC in Oruka Therapeutics, Inc.
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 2,573,308
- Estimated value
- $126,220,757
- Report date
- 01 Jul 2026
- Price
- $49.05
- Ownership
- By Fairmount Healthcare Co-Invest III L.P.
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 2,573,308
- Estimated value
- $126,220,757
- Report date
- 01 Jul 2026
- Price
- $49.05
- Ownership
- By Fairmount Healthcare Co-Invest III L.P.
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 2,573,308
- Estimated value
- $126,220,757
- Report date
- 01 Jul 2026
- Price
- $49.05
- Ownership
- By Fairmount Healthcare Co-Invest III L.P.
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 2,573,308
- Estimated value
- $126,220,757
- Report date
- 01 Jul 2026
- Price
- $49.05
- Ownership
- By Fairmount Healthcare Co-Invest III L.P.
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 2,573,308
- Estimated value
- $126,220,757
- Report date
- 01 Jul 2026
- Price
- $49.05
- Ownership
- By Fairmount Healthcare Co-Invest III L.P.
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 1,131,954
- Estimated value
- $95,570,876
- Report date
- 01 Jul 2026
- Price
- $84.43
- Ownership
- By Fairmount Healthcare Fund II L.P.
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 1,131,954
- Estimated value
- $95,570,876
- Report date
- 01 Jul 2026
- Price
- $84.43
- Ownership
- By Fairmount Healthcare Fund II L.P.
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 1,131,954
- Estimated value
- $95,570,876
- Report date
- 01 Jul 2026
- Price
- $84.43
- Ownership
- By Fairmount Healthcare Fund II L.P.
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 1,131,954
- Estimated value
- $95,570,876
- Report date
- 01 Jul 2026
- Price
- $84.43
- Ownership
- By Fairmount Healthcare Fund II L.P.
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 1,131,954
- Estimated value
- $95,570,876
- Report date
- 01 Jul 2026
- Price
- $84.43
- Ownership
- By Fairmount Healthcare Fund II L.P.
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Series A Non-Voting Convertible Preferred Stock
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 19 Nov 2024
- Price
- $23000.00
- Ownership
- By Fairmount Healthcare Fund II L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 94,497
- Estimated value
- Report date
- 01 Jul 2026
- Price
- Ownership
- By Fairmount Healthcare Fund II L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 94,497
- Estimated value
- Report date
- 01 Jul 2026
- Price
- Ownership
- By Fairmount Healthcare Fund II L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 94,497
- Estimated value
- Report date
- 01 Jul 2026
- Price
- Ownership
- By Fairmount Healthcare Fund II L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 94,497
- Estimated value
- Report date
- 01 Jul 2026
- Price
- Ownership
- By Fairmount Healthcare Fund II L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 94,497
- Estimated value
- Report date
- 01 Jul 2026
- Price
- Ownership
- By Fairmount Healthcare Fund II L.P.
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 9,136
- Estimated value
- Report date
- 02 Jun 2026
- Price
- Ownership
- By: Peter Harwin
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 9,136
- Estimated value
- Report date
- 02 Jun 2026
- Price
- Ownership
- By: Peter Harwin
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 9,136
- Estimated value
- Report date
- 02 Jun 2026
- Price
- Ownership
- By: Peter Harwin
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 9,136
- Estimated value
- Report date
- 02 Jun 2026
- Price
- Ownership
- By: Peter Harwin
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
Oruka Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 9,136
- Estimated value
- Report date
- 02 Jun 2026
- Price
- Ownership
- By: Peter Harwin
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Fairmount Funds Management LLC in Oruka Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.